Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Challenges and Rewards of a Physician Executive Career

Catherine Kolonko  |  Issue: February 2012  |  February 3, 2012

With the career change, Dr. Doyle gained a broader perspective on drug development and, as a physician working in clinical research and development, what it takes to plan and oversee clinical trials. “It’s completely different because you’re not directly involved with individual patient care. You’re looking at data on a trial and population level.”

Too often, the pharmaceutical industry is seen as being represented by an aggressive sales representative who visits medical doctors, says Dr. Doyle, who would like to dispel the notion that working for the pharmaceutical industry is “going to the dark side.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Her work as an executive allows her to continue interactions with key opinion leaders that she knew in academia, and provides insight into cutting-edge science and a chance to collaborate with scientists who develop new compounds, medicines, and mechanisms of action. In her post at Janssen, Dr. Doyle oversees the company’s phase II and III global clinical research trials related to rheumatology. She still enjoys seeing patients as an adjunct professor at Pennsylvania State University and the opportunity to share her clinical trial experience with medical students and colleagues.

Careers in Nonprofit

John H. Klippel, MD, began volunteering for the Arthritis Foundation (AF) early in his career, and in 1999 joined the AF staff as medical director. In 2003 he was named president and CEO.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The Arthritis Foundation has always been important in my life,” says Dr. Klippel. “I think with a background like mine in both rheumatology and research, it allows me to contribute in other ways to an organization that I care about.”

For Dr. Klippel, the risk of different challenges is what attracted him to executive leadership.

“I had to be willing to try something completely new,” notes Dr. Klippel, who says he gets energized by learning new things.

Dr. Klippel obtained his medical degree at the University of Cincinnati College of Medicine. He completed a residency in internal medicine at Yale-New Haven Hospital in Conn., and a fellowship at the National Institutes of Health and the University of California at San Diego. He previously served as Clinical Director of the National Institutes of Arthritis and Musculoskeletal and Skin Diseases and authored arthritis-related publications and textbook chapters during his time at the National Institutes of Health.

In his current position, Dr. Klippel gains additional business and leadership skills through interactions with governing boards across the country, while working on his passion for helping people with a disease he spent years researching.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingProfessional TopicsResearch Rheum Tagged with:CareerCareer developmentdrugpharmacologyResearchrheumatologist

Related Articles

    How Physicians Can Break Into an Executive Position

    February 3, 2012

    To become an effective executive, physicians have to learn to be team players and be prepared that they may not always be the boss.

    Rheumatologists Discuss Opportunities, Benefits Found in Retirement

    May 17, 2018

    Retirement is not always the closing chapter of a long career. For some rheumatologists, it’s the start of new, fulfilling storylines. “I never thought I wouldn’t practice medicine until I was physically unable to do it anymore,” says Harry Gewanter, MD, who retired from his Richmond, Va., pediatric rheumatology practice two years ago. Dr. Gewanter…

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Redefined

    June 15, 2015

    A report from the Institute of Medicine that gives new diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and recommends a new name for the disorder received mixed reviews from rheumatologists and other physicians.1 “Diagnosing ME/CFS often is a challenge … the new diagnostic criteria will make it easier for clinicians to recognize and accurately…

    A Helping Hand for Arthritis Discovery

    February 1, 2007

    Arthritis Foundation supports studies and the researchers behind them

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences